Arsenic trioxide selectively induces acute promyelocytic leukemia cell apoptosis via a hydrogen peroxide-dependent pathway

Blood

Volumn 94, Issue 6, 1999, Pages 2102-2111

  Jing, Yongkui ^a   Dai, Jie ^b   Chalmers Redman, Ruth M E ^b   Tatton, Willam G ^b   Waxman, Samuel ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRIAZOLE; ARSENIC TRIOXIDE; CATALASE; CYTOCHROME; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; HYDROGEN PEROXIDE; THIOMALIC ACID;

ACUTE MYELOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; HUMAN; HUMAN CELL; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL;

EID: 0033568238     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.6.2102     Document Type: Article

References (60)

1. Sun H, Ma L, Hu X, Zhang T: AI-LING I treated 32 cases of acute promyelocytic leukemia. Chin J Integrat Chin West Med 12:170, 1992
2. Huang S, Guo A, Y X, Wang X, Ling H, Fu L: Clinical study on the treatment of acute promyelocytic leukemia mainly with composite Indigo Naturalis tablets. Chin J Hematol 16:26, 1995
3. Zhang P, Wang S, Hu X: Arsenic trioxide treated 72 cases of acute promyelocytic leukemia. Chin J Hematol 17:58, 1996
4. Shen ZX, Chen GQ, Ni JH, Li XS, Xiong SM, Qiu QY, Zhu J, Tang W, Sun GL, Yang KQ, Chen Y, Zhou L, Fang ZW, Wang YT, Ma J, Zhang P, Zhang TD, Chen SJ, Chen Z, Wang ZY: Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood 89:3354, 1997
5. Soignet SL, Maslak P, Wang ZG, Jhanwar S, Calleja E, Dardashti LJ, Corso D, DeBlasio A, Gabrilove J, Scheinberg DA, Pandolfi PP, Warrell RPJJ: Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N Engl J Med 339:1341, 1998
6. Snow ET: Metal carcinogenesis: Mechanistic implications. Pharmacol Ther 53:31, 1992
7. Karagas MR, Tosteson TD, Blum J, Morris JS, Baron JA, Klaue B: Design of an epidemiologic study of drinking water arsenic exposure and skin and bladder cancer risk in a U.S. population. Environ Health Perspect 106:1047, 1998 (suppl 4)
8. 3 induces NB4 cell apoptosis with downregulation of Bc1-2 expression and modulation of PML-RAR alpha/PML proteins. Blood 88:1052, 1996
9. 3 exerts dose-dependent dual effects on APL cells. Blood 89:3345, 1997
10. Shao W, Fanelli M, Ferrara FF, Riccioni R, Rosenauer A, Davison K, Lamph WW, Waxman S, Pelicci PG, Lo Coco F, Avvisati G, Testa U, Peschle C, Gambacorti-Passerini C, Nervi C, Miller WH Jr: Arsenic trioxide as an inducer of apoptosis and loss of PML/RAR alpha protein in acute promyelocytic leukemia cells. J Natl Cancer Inst 90:124, 1998
11. Dai J, Weinberg RS, Waxman S, Jing Y: Malignant cells can be sensitixed to undergo growth inhibition and apoptosis by arsenic trioxide trough modulation of the glutathione redox system. Blood 93:268, 1999
12. Grignani F, Ferrucci PF, Testa U, Talamo G, Fagioli M, Alcalay M, Mencarelli A, Grignani F, Peschle C, Nicoletti I, Pelicci PG: The acute promyelocytic leukemia-specific PML-RAR alpha fusion protein inhibits differentiation and promotes survival of myeloid precursor cells. Cell 74:423, 1993
13. de The H, Lavau C, Marchio A, Chomienne C, Degos L, Dejean A: The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66:675, 1991
14. Lavau C, Dejean A: The t(15;17) translocation in acute promyelocytic leukemia. Leukemia 8:S9, 1994
15. Nervi C, Poindexter EC, Grignani F, Pandolfi PP, Lo Coco F, Avvisati G, Pelicci PG, Jetten AM: Characterization of the PML-RAR alpha chimeric product of the acute promyelocytic leukemia-specific t(15;17) translocation. Cancer Res 52:3687, 1992
16. Benedetti L, Grignani F, Scicchitano BM, Jetten AM, Diverio D, Lo Coco F, Avvisati G, Gambacorti-Passerini C, Adamo S, Levin AA, Pelicci PG, Nervi C: Retinoid-induced differentiation of acute promyelocytic leukemia involves PML-RARalpha-mediated increase of type II transglutaminase. Blood 87:1939, 1996
17. Shao W, Benedetti L, Lamph WW, Nervi C, Miller WH Jr: A retinoid-resistant acute promyelocytic leukemia subclone expresses a dominant negative PML-RAR alpha mutation. Blood 89:4282, 1997
18. Lanotte M, Martin-Thouvenin V, Najman S, Ballerini P, Valensi F, Bergen R: NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood 77:10860, 1991
19. Huang Y, Waxman S: Enhanced apoptosis in leukemia cells following treatment with combination fluoropyrimidines and differentiation inducers. Mol Cell Differ 2:83, 1994
20. Jing Y, Ohizumi H, Kawazoe N, Hashimoto S, Masuda Y, Nakajo S, Yoshida T, Kuroiwa Y, Nakaya K: Selective inhibitory effect of bufalin on growth of human tumor cells in vitro: Association with the induction of apoptosis in leukemia HL-60 cells. Jpn J Cancer Res 85:645, 1994
21. Wadia JS, Charlmes-Redman RME, Ju WJH, Carlile GW, Phillips JL, Fraser AD, Tatton WG: Mitochondrial membrane potential and nuclear changes in apoptosis caused by serum and nerve growth factor withdrawal: time course and modification by (-)-deprenyl. J Neurosci 18:932, 1998
22. Islam KN, Kayanoki Y, Kaneto H, Suzuki K, Asahi M, Fujii J, Taniguchi N: TGF-betal triggers oxidative modifications and enhances apoptosis in HIT cells through accumulation of reactive oxygen species by suppression of catalase and glutathione peroxidase. Free Radic Biol Med 22:1007, 1997
23. Lee TC, Wei ML, Chang WJ, Ho IC, Lo JF, Jan KY, Huang H: Elevation of glutathione levels and glutathione S-transferase activity in arsenic-resistant Chinese hamster ovary cells. In Vitro Cell Dev Biol 25:442, 1989
24. Quillet-Mary A, Jaffrezou JP, Mansat V, Bordier C, Naval J, Laurent G: Implication of mitochondrial hydrogen peroxide generation in ceramide-induced apoptosis. J Biol Chem 272:21388, 1997
25. Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ: Bc1-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75:241, 1993
26. Zhu XH, Shen YL, Jing YK, Cai X, Jia PM, Huang Y, Tang W, Shi GY, Sun YP, Dai J, Wang ZY, Chen SJ, Zhang TD, Waxman S, Chen Z, Chen GQ: Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinjcaiïv achievable concentrations. J Natl Cancer Inst 91:772, 1999
27. Zaman GJ, Lankelma J, van Tellingen O, Beijnen J, Dekker H, Paulusma C, Oude Elferink RP, Baas F, Borst P: Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein. Proc Natl Acad Sci USA 92:7690, 1995
28. Muller M, Meijer C, Zaman GJ, Borst P, Scheper RJ, Mulder NH, de Vries EG, Jansen PL: Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proc Natl Acad Sci USA 91:13033, 1994
29. Chada S, Whitney C, Newburger PE: Post-transcriptional regulation of glutathione peroxidase gene expression by selenium in the HL-60 human myeloid cell line. Blood 74:2535, 1989
30. Tappel AL: Selenium-glutathione peroxidase: properties and synthesis. Curr Top Cell Regul 24:87, 1984
31. Decaudin D, Marzo I, Brenner C, Kroemer G: Mitochondria in chemotherapy-induced apoptosis: A prospective novel target of cancer therapy. Int J Oncol 12:141, 1998
32. Slater AF, Stefan C, Nobel I, van den Dobbelsteen DJ, Orrenius S: Signalling mechanisms and oxidative stress in apoptosis. Toxicol Lett 82-83: 149, 1995
33. Slater AF, Nobel CS, Orrenius S: The role of intracellular oxidants in apoptosis. Biochim Biophys Acta 1271:59, 1995
34. Simizu S, Takada M, Umezawa K, Imoto M: Requirement of caspase-3(-like) protease-mediated hydrogen peroxide production for apoptosis induced by various anticancer drugs. J Biol Chem 273:26900, 1998
35. Larrick JW, Wright SC: Cytotoxic mechanism of tumor necrosis factor-alpha. FASEB J 4:3215, 1990
36. Devary Y, Rosette C, DiDonato JA, Karin M: NF-kappa B activation by ultraviolet light not dependent on a nuclear signal. Science 261:1442, 1993
37. Manome Y, Datta R, Taneja N, Shafman T, Bump E, Hass R, Weichselbaum R, Kufe D: Coinduction of c-jun gene expression and internucleosomal DNA fragmentation by ionizing radiation. Biochemistry 32:10607, 1993
38. Quillet-Mary A, Mansat V, Duchayne E, Come MG, Allouche M, Bailly JD, Bordier C, Laurent G: Daunorubicin-induced internucleosomal DNA fragmentation in acute myeloid cell lines. Leukemia 10:417, 1996
39. Chance B. Sies H, Boveris A: Hydroperoxide metabolism in mammalian organs. Physiol Rev 59:527, 1979
40. Wang HF, Lee TC: Glutathione S-transferase pi facilitates the excretion of arsenic from arsenic-resistant Chinese hamster ovary cells. Biochem Biophys Res Commun 192:1093, 1993
41. Wang TS, Kuo CF, Jan KY, Huang H: Arsenite induces apoptosis in Chinese hamster ovary cells by generation of reactive oxygen species. J Cell Physiol 169:256, 1996
42. Chen YC, Lin-Shiau SY, Lin JK: Involvement of reactive oxygen species and caspase 3 activation in arsenite-induced apoptosis. J Cell Physiol 177:324, 1998
43. Cantoni O, Hussain S, Guidarelli A, Cattabeni F: Cross-resistance to heavy metals in hydrogen peroxide-resistant CHO cell variants. Mutat Res 324:1, 1994
44. Wang TS, Shu YF, Liu YC, Jan KY, Huang H: Glutathione peroxidase and catalase modulate the genotoxicity of arsenite. Toxicology 121:229, 1997
45. Kowaltowski AJ, Netto LES, Vercesi AE: The thiol-specific antioxidant enzyme prevents mitochondrial permeability transition. J Biol Chem 273:12766, 1998
46. Marchetti P, Decaudin D, Macho A, Zamzami N, Hirsch T, Susin SA, Kroemer G: Redox regulation of apoptosis: Impact of thiol oxidation status on mitochondrial function. Eur J Immunol 27:289, 1997
47. Satoh T, Enokido Y, Aoshima H, Uchiyama Y, Hatanaka H: Changes in mitochondrial membrane potential during oxidative stress-induced apoptosis in PC12 cells. J Neurosci Res 50:413, 1997
48. Yang JC, Cortopassi GA: Induction of the mitochondrial permeability transition causes release of the apoptogenic factor cytochrome c. Free Radic Biol Med 24:624, 1998
49. Stridh H, Kimland M, Jones DP, Orrenius S, Hampton MB: Cytochrome c release and caspase activation in hydrogen peroxide-and tributyltin-induced apoptosis. FEBS Lett 429:351, 1998
50. Ma DC, Sun YH, Chang KZ, Ma XF, Huang SL, Bai YH, Kang J, Liu YG, Chu JJ: Selective induction of apoptosis of NB4 cells from G2+M phase bysodium arsenite at lower doses. Eur J Haematol 61:27, 1998
51. Akao Y, Mizoguchi H, Kojima S, Naoe T, Ohishi N, Yagi K: Arsenic induces apoptosis in B-cell leukaemic cell lines in vitro: Activation of caspases and down-regulation of Bc1-2 protein. Br J Haematol 102:1055, 1998
52. Lo HW, Ali Osman F: Genomic cloning of hGSTP1*C, an allelic human Pi class glutathione S-transferase gene variant and functional characterization of its retinoic acid response elements. J Biol Chem 272:32743, 1997
53. Mukherjee G, Banerjee D, Bhattacharya DK, Chatterjee GC: Effect of retinoic acid on adenosine diphosphate and collagen-induced alterations in enzymes of GSH-linked antioxidant defence system of human blood platelets in vitro. Indian J Exp Biol 28:550, 1990
54. Raelson JV, Nervi C, Rosenauer A, Benedetti L, Monczak Y, Pearson M, Pelicci PG, Miller WH Jr: The PML/RAR alpha oncoprotein is a direct molecular target of retinoic acid in acute promyelocytic leukemia cells. Blood 88:2826, 1996
55. Puccetti E, Sternsdorf T, Hoelzer D, Will H, Ottmannh OG, Ruthardt M: PIC-1/SUMO-1 modified PML/RARa is directly involved in arsenic trioxide induced apoptosis in acute promyelocytic leukemia. Blood 92:212a, 1998 (abstr, suppl 1)
56. Niu C, Yan H, SUN HP, Liu JX, Gu XY, Su XY, Cao Q, Waxman S, Chen Z, Chen SJ, Shen ZX, Wang ZY: Treatment of de novo and relapsed acute promyelocytic leukemia patients with arsenic trioxide. Blood 92:678a, 1998 (abstr. suppl 1)
57. Chou TC, Zhang XG, Balog A, Su DS, Meng D, Savin K, Bertino JR, Danishefsky SJ: Desoxyepothilone B: An efficacious microtubule-targeted antitumor agent with a promising in vivo profile relative toepothilone B. Proc Natl Acad Sci USA 95:9642, 1998
58. Rappa G, Lorico A, Flavell RA, Sartorelli AC: Evidence that the multidrug resistance protein (MRP) functions as a co-transporter of glutathione and natural product toxins. Cancer Res 57:5232, 1997
59. Lallemand V, Guillemini MC, Janin A, Degos L, Kogan S, Bishop M, de The H: Combined retinoic acid and arsenic therapy sharply enhances survival in a mouse APL model. Blood 92:483a, 1998 (abstr, suppl 1)
60. Zhang W, Ohnishi K, Shigeno K, Fujisawa S, Naito K, Nakamura S, Takeshita K, Takeshita A, Ohno R: The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms. Leukemia 12:1383, 1998